Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis
Clinical trial NCT01378429 · COMPLETED
Trial details
- NCT number
- NCT01378429
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2011-11-01
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.